InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-2.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Crane Rosemary A, Director. Officer active across 4 companies, notably Teva Pharmaceutical Industries Ltd. Aggregated, 19 filings have been recorded. Activity tracked since 28 October 2021. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
14,492 sharesOrdinary SharesSEC:0001193125-26-261706:0
15,757 shares0Common StockSEC:0001443343-26-000003
15,757 shares0Common StockSEC:0001443343-26-000003:0
11,928 shares0Common StockSEC:0001415889-25-014190:0
3,350 sharesCommon StockSEC:0001819790-24-000104:0
21,108 sharesOrdinary SharesSEC:0000950170-24-074022:0
8,663 shares0Common StockSEC:0001415889-24-014283:0
6,993 shares0Common StockSEC:0001596783-23-000155:0
15,810 sharesOrdinary SharesSEC:0001209191-23-044772:0
2,000 sharesCommon StockSEC:0001819790-23-000046:0
9,324 shares0Common StockSEC:0001415889-23-008750:0
4,149 shares0Common StockSEC:0001596783-22-000167:0
14,479 sharesOrdinary SharesSEC:0001209191-22-037245:0
1,402 shares0Common StockSEC:0001596783-21-000171:0
1,402 shares0Common StockSEC:0001596783-21-000171
12,668 sharesOrdinary SharesSEC:0001209191-21-039368:0
12,668 sharesOrdinary SharesSEC:0001209191-21-039368
6,041 sharesOrdinary SharesSEC:0001209191-21-038820:0
6,041 sharesOrdinary SharesSEC:0001209191-21-038820
19 of 19 declarations
About Crane Rosemary A
Rosemary A. Crane is a Director at TEVA PHARMACEUTICAL INDUSTRIES LTD, Catalent, Inc., and Certara, Inc. As a board member, she participates in governance and strategic decision-making. Her experience in the pharmaceutical industry allows her to provide valuable insights to guide the companies' policies and initiatives.
